Health Insurance & Protection is part of the Business Intelligence Division of Informa PLC

Informa PLC | About us | Investor relations | Talent

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Cancer Essentials from Lime


Pros

Cons
Simple to buy cancer cover.Annually renewable, so potentially subject to annual change and premiums attract IPT.
Inexpensive.Relatively low lump sum benefit so not an alternative to full CI cover.
Three elements: small cash lump sum; £100K drug fund; help and support.Online only rather than a broker product.

The Product

This policy is a direct-to-consumer version of Aviva’s Cancer Essentials product and is underwritten by Aviva Insurance.

Premiums start from just £2.03 per month for an 18-year-old non-smoker, or £3.16 per month for a 37-year-old non-smoker.

The annually renewable policy offers up to £100,000 to pay for the cost of drugs recommended by the patient’s NHS specialist but not funded by their NHS health trust.

On diagnosis of cancer, the product pays a one-off cash benefit of £5,000.

There is also a cancer helpline offering advice and information from trained specialists.

Customers cannot be covered if they have had cancer within the past ten years. Non melanoma skin cancer and prostate cancer with no active treatment recommended are both excluded too. Cover is available to age 70.

What they say

CEO Shaun Williams said: “Cancer is a real and genuine fear for many people. Thankfully, survival rates are starting to improve, but insurance just hasn’t changed, until now.

At Lime, we are innovating and making cancer cover available and affordable for all. We want everyone to have the health insurance cover they know they need and deserve.”

What we say

This is not a new product (we reviewed it back in 2016) but what’s different is that Lime is offering it online and as part of a wider portfolio of products and solutions under the heading of ‘doing insurance properly’.

Lime has a relaxed online style, written in a way to appeal to people who perhaps shy away from more traditional insurance distributors. The application process seems very straightforward and quick too – although we couldn’t find set out anywhere some important information about the product – such as in what exact circumstances the policy will pay out. You need to contact Lime to find out (or look up the T&Cs on Aviva’s website).

The product itself is a slightly odd mix of three things – a £5K CI style lump sum on diagnosis of cancer, a £100K pot that can be used to pay for drugs not funded by the NHS and helplines.

Unlike most CI plans, it’s an annually renewable product, which means premiums attract IPT (at 12% currently).